Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
Clinical trial NCT03128879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03128879
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-16
- Primary completion
- 2027-05-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.